AZ64 inhibits TrkB and enhances the efficacy of chemotherapy and local radiation in neuroblastoma xenografts
Radhika Iyer(Children's Hospital of Philadelphia), Garrett M. Brodeur(Children's Hospital of Philadelphia), Kenneth S. Thress(AstraZeneca (United States)), Carly R. Varela(Children's Hospital of Philadelphia), Huaqing Zhao(Children's Hospital of Philadelphia), Ruth Ho(Children's Hospital of Philadelphia), Jane E. Minturn(St Nicholas Hospital), Anisha M. Simpson(Children's Hospital of Philadelphia), Jeffrey L. Brown(Harvard University), Audrey E. Evans(Purdue University West Lafayette), Jennifer E. Light(Children's Hospital of Philadelphia)
Cited by 26
Related Papers
Revisions of the international criteria for neuroblastoma diagnosis, staging, and response to treatment.
|Journal of Clinical Oncology|1993|2.3k
Acquired EGFR C797S mutation mediates resistance to AZD9291 in non–small cell lung cancer harboring EGFR T790M
|Nature Medicine|2015|1.5k
Interleukin-1 Receptor Blockade Is Associated With Reduced Mortality in Sepsis Patients With Features of Macrophage Activation Syndrome
|Critical Care Medicine|2015|858
Association Between Plasma Genotyping and Outcomes of Treatment With Osimertinib (AZD9291) in Advanced Non–Small-Cell Lung Cancer
|Journal of Clinical Oncology|2016|843